NYMOX
Manufacturing · Bahamas · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Bay & Deveaux Sts, Nassau, New Providenc...Phone Number
(800) 936-9669Website
www.nymox.comRevenue
<$5 MillionStock Symbol
NYMXIndustry
About NYMOX
Nymox Pharmaceutical Corporation is focused on developing innovative therapies for men suffering from Benign Prostate Hyperplasia (BPH). Their flagship product, Fexapotide Triflutate, is a novel injectable therapy that specifically targets prostate gland cells. The company also offers NicAlert and TobacAlert products, aimed at addressing smoking-related health issues. Nymox's intended clients include men with BPH and low-grade localized prostate cancer, as well as medical tourists seeking prostate treatments.Explore more
NYMOX Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
NYMOX Tech Stack
A closer look at the technologies used by NYMOX
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NYMOX
Sign Up For FreeTo access detailed company insights
Nymox Pharmaceutical Corporation is focused on developing innovative therapies for men suffering from Benign Prostate Hyperplasia (BPH). Their flagship product, Fexapotide Triflutate, is a novel injectable therapy that specifically targets prostate gland cells. The company also offers NicAlert and TobacAlert products, aimed at addressing smoking-re... Read More
